Inventor
UY JOHNNY
US23 patents
⚠️ This page may combine multiple inventors who share the name “UY JOHNNY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
16 patentsUS9782408B2Oct 10, 2017
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA33 citations97
US10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US10758534B2Sep 1, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA13 citations93
US10570115B2Feb 25, 2020
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA23 citations93
US10258624B2Apr 16, 2019
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA32 citations93
US11426407B2Aug 30, 2022
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations85
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11186566B2Nov 30, 2021
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA10 citations84
US11066417B2Jul 20, 2021
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA13 citations84
US12421251B2Sep 23, 2025
Cystic fibrosis transmembrane conductance regulator modulating agents
VERTEX PHARMA5 citations73
US11866450B2Jan 9, 2024
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA3 citations73
US12168009B2Dec 17, 2024
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA1 citations72
US10738030B2Aug 11, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations71
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
US9403839B2Aug 2, 2016
Pyran-spirocyclic piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations41
US10233191B2Mar 19, 2019
Fused piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations39
HUSFELD CRAIG
4 patentsUS8202891B2Jun 19, 2012
Quaternary ammonium compounds useful as muscarinic receptor antagonists
HUSFELD CRAIG2 citations61
US9216971B2Dec 22, 2015
Quaternary ammonium compounds useful as muscarinic receptor antagonists
HUSFELD CRAIG0 citations51
US8815907B2Aug 26, 2014
Quaternary ammonium compounds useful as muscarinic receptor antagonists
HUSFELD CRAIG0 citations51
US8492407B2Jul 23, 2013
Quaternary ammonium compounds useful as muscarinic receptor antagonists
HUSFELD CRAIG0 citations51